Agents Requiring a Permit for Subsequent Distribution

Some materials require additional approval before they can be transferred by the original permit holder to an additional recipient.

Subsequent transfers are not permitted for materials suspected or known to contain the following infectious biological agents:

• Mycobacterium tuberculosis
• Coronaviruses (SARS-CoV-2, MERS-CoV)
• Influenza viruses (H2N2, H6N1, low pathogenic avian H7N9)
• Viral hemorrhagic fevers (e.g., Tick-borne encephalitis viruses – Central European subtypes, Old World hantaviruses that cause hemorrhagic fever with renal syndrome (HFRS))
• Mpox (clade II) (formerly known as: Monkeypox – West African clade)
• Poliovirus (serotypes 1, 2, 3)

All subsequent transfers of these agents require the intended recipient to submit a new permit application for approval.

This process is effective as of December 14, 2023.